|
|
Article: Scientists at Merck & Company, Inc. report research in antisense technology.
- Article from:
- Gene Therapy Weekly
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
According to recent research from the United States, "The emergence of drug-resistant bacteria coupled with the limited discovery of novel chemical scaffolds and druggable targets inspires new approaches to antibiotic development. Here we describe a chemical genomics strategy based on 245 Staphylococcus aureus antisense RNA strains, each engineered for reduced expression of target genes essential for S. aureus growth."
"Attenuation of gene expression can sensitize cells to compounds that inhibit the activity of a gene product or associated process. Pools of strains grown competitively in the presence of bioactive compounds generate characteristic profiles of ...
Related newspaper, magazine, and journal articles:
|
|
Article: New antisense technology study findings have been ...
Gene Therapy Weekly;
April 30, 2009 ;
700+ words
... ... and colleagues (see also Antisense Technology). The researchers concluded ... States, Gaithersburg, Antisense Technology, Biotechnology, Gene Therapy, Treatment. This article was prepared by Gene Therapy Weekly editors from staff ...
|
|